We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Hypoxia in Preterm Babies May Lead to Cognitive Defects

By HospiMedica staff writers
Posted on 06 Feb 2003
A study has found that reduced blood oxygen levels soon after birth, especially in preterm babies, are associated with lower intelligent quotients (IQs) and language skills later on. More...
The study was published in the January 2003 issue of Neuropsychology.

The study also revealed that the risk threshold for brain damage in preterm babies could be lower than previously thought. In the study, psychologists compared the intellectual and language development of 52 children five and six years old born prematurely. Half were at slight-to-moderate risk for hypoxia. The other half had no such risk. Despite the small difference between the groups in the degree of risk, the researchers found that the two groups "diverged significantly” in their development.

This finding contradicts established thinking that regards severe oxygen deprivation as the threshold for brain damage as an all-or-nothing matter. For example, the preterm group, with mild to moderate acidosis, scored about 10-11 points lower on verbal and visuospatial tests than the low-risk preterm group.

"Most neonatologists would probably not expect to find a statistically significant relationship between degree of acidosis measured soon after birth and performance on cognitive tests in preschool and early school-age children, when acidosis is only mild to moderate at worst,” said Sarah Raz, Ph.D., a co-author from Wayne State University (Detroit, MI, USA).

Knowledge of how early risk factors affect cognitive abilities should help doctors evaluate the effectiveness of medical interventions that support preterm infants during and after birth, say the researchers.




Related Links:
Wayne State U.

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.